📢Join us for the upcoming post The EBMT webinar!

Round Table Debate Dedicated to the Hottest Findings from EBMT 2024

🗓️April 23 2024
⏲️6PM CET, 12PM NY

Register for FREE👇
bit.ly/3Wksl8f

Bipin Savani Florent Malard Arnon Nagler Mohamad Mohty

Outstanding presentation by Corey Cutler at #EBMT24 on belumosudil for chronic GvHD (ROCKstar study)

After 3 years' follow-up, the larger study population behaved similarly to the population at 1 year and continued to have a good response to belumosudil with no new safety concern

🆕 We are thrilled to introduce the new Educational Library! 📚 Explore EBMT's educational event recordings, recommended publications, guidelines nd specialised handbooks in this brand-new open-access platform. 💻👨‍🏫 ➡️ library.ebmt.org

#MedTwitter #BMTsm

Looking forward to Chair the Oral Session 15 The EBMT, Predicting and Managing HSCT complications, starting 1230 today and see some fantastic presentations on Final day of the congress..

come join #EBMT24 Nico Gagelmann Mohamad Mohty vp Antonio Pagliuca

Many congratulations raffaellagreco

BMT CTN 1801 scientific update presented by Leslie Kean in the presidential symposium The EBMT with fascinating deep insights into biological effects following PTCY use - congratulations BMT CTN !@DrLeslieKean #EBMT24

Patients with favorable-risk AML who had NPM1 mutation have poor prognosis if they also harbor mutations highly specific for sMut. ow.ly/nXqg50QMWBR #myeloidneoplasia

🎉Finally out🎉

Management of adult patients with CMML undergoing allogeneic hematopoietic cell transplant: recommendations from ⁦The EBMT⁩

⁦Blood Journal⁩ #mpnsm ashpublications.org/blood/article/…

A great end to Day 1 of Fungal Update Meeting 20th Edition.
Some inspiring Talks to help move the field further!
Thanks Samir Agrawal for leading it.
Next stop House of Lords 😊🍴

Fungal Update ECMM Neil Stone Mansour Ceesay

1/x Much awaited BMT CTN 1506 trial out in Journal of Clinical Oncology establishing gilteritinib as SOC post #alloBMT maintenance in #MRD +ve FLT3-ITD #AML pts in CR1; thanks to a global collaboration funded by Astellas Pharma US NIH NHLBI and National Cancer Institute to BMT CTN tweetorial👇
ascopubs.org/doi/pdf/10.120…

👉🏼👉🏼Potential benefits of Treosulfan based - regimens compared to Busulfan in allo-HCT for Myelofibrosis - new retrospective study by Marie Robin and colleagues from the CMWP: ☑️potential improvement in PFS; prospective study is needed ! The EBMT The EBMT_Trainee #MPNsm

Important alert to all transplanters! Every #TransplantAllogeneic Doc who sees #MDSsm patients should read this paper by ⁦Coleman Lindsley⁩ !! Please do NOT decline to transplant otherwise eligible TP53-mut higher risk #MDSsm Pts who have donors ascopubs.org/doi/10.1200/JC…

Two weeks left until everything kicks off at #Mycology2024 ! 🎙️🔬

This exciting 2-day conference boasts cutting edge-research, panel discussions, poster exhibitions, CPD accreditation, and much more!

Register now 👉 ow.ly/9CTt50QJLjA #Conference

CONGRESS | #Tandem24
Zachariah DeFilipp summarizes data from the AGAVE-201 study, which met the primary endpoint. Dose levels of axatilimab were assessed in pts with R/R chronic #GvHD . Findings from the 0.3mg/kg Q2W dose were presented; by cycle 7 ORR was 74%.
Mass General Cancer Center

Latest paper from COMMAND consortium. HMA vs HMA+Ven for #TP53m AML

HMA+Ven ↑ CR and DOR; bridge to allo_HCT.

Didn't ↑ OS compared to HMA alone.

Question now: should elderly, frail, pts Rx with HMA+Ven or HMA?

#leusm
nature.com/articles/s4140…

Calling all medical mycology enthusiasts residing in low-middle income countries! 📣

Unlock FREE online access to #Mycology2024 and enjoy endless opportunities to engage with experts, explore new research, and expand your network

Register now! 👇
mycologyconference.co.uk/#registration

🔥📰Our 5th Global guideline with
ISHAM
&
ASM endorsed IDSA

CRYPTOCOCCOSIS

Led by C. Chang &
John Perfect

Plus Andrej Spec, MD, MSCI Nelesh Govender Ferry Hagen 🔬🧫🧬 Oliver Cornely Peter G Pappas David Boulware, MD MPH Tihana Bicanic Martin Hoenigl🇺🇦🇦🇹 JP Gangneux

thelancet.com/journals/lanin…

Don't miss Session 8 at #Mycology2024 , where real-world challenges meet expert insights! 🍄🧠

Chair Tihana Bicanic hosts Groll Andreas, Rohit Saha, and Neil Stone for interactive case studies on managing invasive fungal infections.

Register now 👇
ow.ly/vNQx50QzCOB

🌟 New The EBMT recommendations on #AutoimmuneDiseases undergoing innovative #CTs are now available in eClinicalMedicine – The Lancet Discovery Science. Thanks to all the experts who contributed! Read more: authors.elsevier.com/sd/article/S25….

Interesting new paper in Nature Communications from the French VEXAS group using cytokine profiling, CyTOF and RNAseq shows inflammasome activation and inflammatory cell death as key features of #VEXAS . nature.com/articles/s4146… 1/2